Cambodia has achieved remarkable success in reducing annual new HIV infections, from an estimated 15,000 in 1996 to 1,400 in
2022. However, rising HIV incidence among young people aged 15-24, particularly among men who have sex with men (MSM),
transgender women (TG), and people engaged in sexualized drug use (chemsex) is counteracting reductions in new infections.
 

The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions into their ongoing monitoring efforts and to report comprehensive national data through the Global AIDS Monitoring (GAM) process.

This information brief is intended for key population networks and other community-led and community-based organizations to help them better understand how to request funding support for community-led monitoring (CLM) in 2023-2025 applications to the Global Fund. The brief has been jointly developed by TREAT Asia/amfAR and the International Treatment Preparedness Coalition (ITPC).

The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.

The 2022 edition of the report is as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2022, 202 countries and territories with more than 99% of the world’s population and TB cases reported data.

Facilitating access to formulations of the HIV medicine dolutegravir (DTG) that can be used by infants and children living with HIV in the Asia-Pacific is an urgent concern.

In light of recent U.S. and European regulatory approvals of a dispersible version of pediatric DTG, amfAR’s TREAT Asia program recommends steps that national HIV programs and advocacy groups can take in order to secure access to this medicine as quickly as possible.

This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic triad are proposed.

The main goal of the study was to estimate the prevalence of HIV, syphilis, Chlamydia and Gonorrhoea among female entertainment workers in Cambodia.

This report describes the HIV epidemic among young people from key populations in the region, takes stock of HIV programmes for such people, and pinpoints the priority actions that will speed up progress towards ending the AIDS epidemic as a public health threat in the region.

Progress in prevention and treatment is faltering around the world, putting millions of people in grave danger. Eastern Europe and central Asia, Latin America, and the Middle East and North Africa have all seen increases in annual HIV infections over several years. In Asia and the Pacific, UNAIDS data now show new HIV infections are rising where they had been falling. Action to tackle the inequalities driving AIDS is urgently required to prevent millions of new HIV infections this decade and to end the AIDS pandemic.